CONMED Corporation (CNMD)
NYSE·Healthcare·Medical - Devices
$36.69
-3.12%
Mkt Cap $1.16B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Jan 28, 2026 | $366.88M | $373.20M | +1.72% | $1.32 | $1.43 | +8.33% | — | — |
| Q4 2025 Nov 5, 2025 | $366.88M | $337.93M | -7.89% | $1.05 | $1.08 | +2.86% | — | — |
| Q3 2025 Jul 30, 2025 | $334.60M | $342.35M | +2.32% | $1.13 | $1.15 | +1.77% | — | — |
| Q2 2025 Apr 30, 2025 | $313.38M | $321.26M | +2.51% | $0.81 | $0.95 | +17.28% | — | — |
| Q1 2025 Feb 5, 2025 | $341.05M | $347.93M | +2.02% | $1.20 | $1.34 | +11.67% | — | — |
| Q4 2024 Oct 30, 2024 | $318.13M | $316.70M | -0.45% | $0.99 | $1.05 | +6.06% | — | — |
| Q3 2024 Jul 31, 2024 | $332.32M | $330.75M | -0.47% | $0.91 | $0.98 | +7.69% | — | — |
| Q2 2024 Apr 24, 2024 | $306.78M | $311.63M | +1.58% | $0.74 | $0.79 | +6.76% | — | — |
| Q1 2024 Jan 31, 2024 | $332.20M | $327.05M | -1.55% | $1.11 | $1.06 | -4.50% | — | — |
| Q4 2023 Oct 25, 2023 | $300.91M | $304.58M | +1.22% | $0.83 | $0.90 | +8.43% | — | — |
| Q3 2023 Jul 26, 2023 | $306.09M | $317.65M | +3.78% | $0.79 | $0.83 | +5.06% | — | — |
| Q2 2023 Apr 26, 2023 | $266.67M | $295.47M | +10.80% | $0.60 | $0.66 | +10.00% | — | — |
| Q1 2023 Feb 2, 2023 | $302.48M | $250.87M | -17.06% | $0.93 | $0.42 | -54.84% | — | — |
| Q4 2022 Oct 26, 2022 | $280.83M | $275.09M | -2.04% | $0.75 | $0.77 | +2.67% | — | — |
| Q3 2022 Jul 27, 2022 | $275.75M | $277.19M | +0.52% | $0.76 | $0.76 | +0.00% | — | — |
| Q2 2022 May 4, 2022 | $235.77M | $242.33M | +2.78% | $0.62 | $0.70 | +12.90% | — | — |
| Q1 2022 Jan 26, 2022 | $275.82M | $273.97M | -0.67% | $1.03 | $1.07 | +3.88% | — | — |
| Q4 2021 Oct 27, 2021 | $256.26M | $248.83M | -2.90% | $0.77 | $0.80 | +3.90% | — | — |
| Q3 2021 Jul 28, 2021 | $248.50M | $255.16M | +2.68% | $0.62 | $0.71 | +14.52% | — | — |
| Q2 2021 Apr 28, 2021 | $216.88M | $232.68M | +7.28% | $0.43 | $0.63 | +46.51% | — | — |